Imperial College London

DrTomWong

Faculty of MedicineNational Heart & Lung Institute

Reader in Cardiology
 
 
 
//

Contact

 

+44 (0)20 7351 8619tom.wong

 
 
//

Assistant

 

Dr Vias Markides +44 (0)20 7351 8619

 
//

Location

 

Chelsea WingRoyal Brompton Campus

//

Summary

 

Summary

Dr Tom Wong is Consultant Electrophysiologist and Cardiologist at Royal Brompton and Harefield NHS Foundation Trust. He is the clinical lead of the Arrhythmia Services and the research lead of the Arrhythmia Group across the Royal Brompton and Harefield sites. 

He graduated from University of Aberdeen in 1993, underwent cardiology and electrophysiology training in London, before his consultant appointment in 2006.

Dr Tom Wong’s career focuses on providing the best clinical care to patients with heart rhythm abnormalities and exploring avenues to further improve care through research and innovation. 

His research program relates to his clinical interests to seek better understanding and treatment of arrhythmias in advanced disease states and complex cardiac anatomies.

Dr Tom Wong conducted ARC-HF clinical trial, first to show the beneficial effects of catheter ablation in cardiopulmonary performance compared to drug therapy in patients with persistent atrial fibrillation and heart failure. He published the cost impact of the left atrial appendage closure in stroke prevention based upon the UK cost model to inform the economic benefit, beyond the clinical needs, of this treatment to patient at risk of stroke. He is the chief investigator of CASA-AF trial, funded by NIHR, to compare catheter and thoracoscopic ablation approaches to treat persistent atrial fibrillation. In addition, he has and continue to investigate novel mapping, ablation and device related technologies with an aim to improve clinical outcomes.

Publications

Journals

Gandjbakhch E, Laredo M, Berruezo A, et al., 2021, Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy., Europace, Vol:23, Pages:1428-1436

Hind M, Wong T, 2021, Atrial Fibrillation, Obstructive Sleep Apnea, and Continuous Positive Airway Pressure: No Easy Fix., Am J Respir Crit Care Med, Vol:204, Pages:503-505

Simard T, Jung RG, Lehenbauer K, et al., 2021, Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion, Journal of the American College of Cardiology, Vol:78, ISSN:0735-1097, Pages:297-313

Shi R, Chen Z, Pope MTB, et al., 2021, Individualized ablation strategy to treat persistent atrial fibrillation: Core-to-boundary approach guided by charge-density mapping, Heart Rhythm, Vol:18, ISSN:1547-5271, Pages:862-870

Ali AN, Riad O, Tawfik M, et al., 2021, Newer generation cryoballoon vs. contact force-sensing radiofrequency ablation catheter in the ablation of paroxysmal atrial fibrillation., Herzschrittmacherther Elektrophysiol, Vol:32, Pages:236-243

More Publications